Early outcomes from a phase II randomized trial testing stereotactic body radiation therapy in patients undergoing I line treatment with abiraterone acetate for oligometastatic castration resistant prostate cancer (ARTO trial-NCT03449719)

G. Francolini, A. G. Allegra, S. Caini,B. Detti,V. Di Cataldo,A. Alitto, S. Parisi, R. M. D'Angelillo,A. Bruni,G. Ingrosso,G. Timon, L. Burchini, G. Frosini, M. Valzano, M. Ganovelli, I. Desideri, L. Visani, E. Olmetto, C. Becherini,V. Salvestrini, A. Lapini, I. Meattini, L. Livi

European Urology（2023）

引用 0|浏览12

暂无评分

关键词

stereotactic body radiation therapy,resistant prostate cancer,prostate cancer,radiation therapy,abiraterone acetate,trial-nct

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要